Breast cancer patients with government insurance at higher risk of death

(ECOG-ACRIN Cancer Research Group) A retrospective study of 9800 women with breast cancer who participated in randomized clinical trials found that Medicaid/Medicare patients were less likely to participate in a clinical trial compared to their privately insured counterparts. The few who did were more likely to stop treatment early and had lower survival. The study was conducted by researchers in the ECOG-ACRIN Cancer Research Group with funding from the National Cancer Institute, part of the Na...